Hjem › Blodcancer
Blodcancer kliniske forsøg rekrutterer i USA
153 studier for Blodcancer rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX46 studier
- New York City, NY26 studier
- Boston, MA25 studier
- Washington, DC19 studier
- Baltimore, MD18 studier
- Seattle, WA18 studier
- Los Angeles, CA17 studier
- Durham, NC16 studier
- Chicago, IL15 studier
- Philadelphia, PA14 studier
- Nashville, TN13 studier
- Atlanta, GA13 studier
- Edison, NJ13 studier
- Columbus, OH13 studier
- Baldwin Park, CA13 studier
- Milwaukee, WI12 studier
- Dallas, TX12 studier
- Detroit, MI12 studier
- Minneapolis, MN11 studier
- Birmingham, AL11 studier
- Ann Arbor, MI11 studier
- Omaha, NE10 studier
- Cincinnati, OH10 studier
- St. Louis, MO10 studier
- Jacksonville, FL10 studier
- Miami, FL9 studier
- Memphis, TN9 studier
- Denver, CO9 studier
- Cedar Rapids, IA9 studier
- San Francisco, CA8 studier
- Clifton, NJ8 studier
- Salt Lake City, UT8 studier
- San Antonio, TX8 studier
- Aurora, CO8 studier
- Tampa, FL8 studier
- Buffalo, NY7 studier
- Madison, WI7 studier
- Grand Rapids, MI7 studier
- Charlotte, NC7 studier
- Portland, OR7 studier
Efter delstat
- Alabama11 studier
- Arizona12 studier
- Arkansas5 studier
- Californien35 studier
- Colorado14 studier
- Connecticut8 studier
- Delaware3 studier
- District of Columbia7 studier
- Florida28 studier
- Georgia16 studier
- Illinois16 studier
- Indiana9 studier
- Iowa9 studier
- Kansas7 studier
- Kentucky10 studier
- Louisiana6 studier
- Maryland29 studier
- Massachusetts26 studier
- Michigan22 studier
- Minnesota17 studier
- Missouri11 studier
- Nebraska10 studier
- Nevada4 studier
- New Hampshire3 studier
- New Jersey21 studier
- New York29 studier
- North Carolina24 studier
- Ohio22 studier
- Oklahoma8 studier
- Oregon8 studier
- Pennsylvania21 studier
- Rhode Island4 studier
- South Carolina8 studier
- South Dakota5 studier
- Tennessee20 studier
- Texas49 studier
- Utah8 studier
- Virginia11 studier
- Washington20 studier
- West Virginia5 studier
- Wisconsin15 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RekruttererObservationsstudie
Alder 18 til 110 · Alle køn · Opdateret 2. okt. 2026 · NCT05724121Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT06904066Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069Rutgers University Study of the Genetics of Blood Cancers
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 110 · Alle køn · Opdateret 1. okt. 2026 · NCT07714044Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservationsstudie
Alder 0 til 38 · Alle køn · Opdateret 1. okt. 2026 · NCT06131801A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06697184A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07572006A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT04634552Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06910969Genomic Profiling in Cancer Patients
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 24. sep. 2026 · NCT01775072Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RekruttererTidlig fase 1
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06398457Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT04728893Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruttererFase 3
Alder 18 til 71 · Alle køn · Opdateret 23. sep. 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345Wearable Activity Tracking to Curb Hospitalizations
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT06587100Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
RekruttererTidlig fase 1
Alder 12 til 80 · Alle køn · Opdateret 23. sep. 2026 · NCT04744116Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 12 til 120 · Alle køn · Opdateret 22. sep. 2026 · NCT05470491Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
RekruttererFase 1
Alder 18 til 75 · Alle køn · Opdateret 21. sep. 2026 · NCT07162038Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07648264Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 18. sep. 2026 · NCT07743476Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 12 til 120 · Alle køn · Opdateret 18. sep. 2026 · NCT05327023Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. sep. 2026 · NCT04242095SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT05375643Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
RekruttererFase 1
Op til 75 år · Alle køn · Opdateret 16. sep. 2026 · NCT06345027Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.